Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset.
about
Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cellsImmunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Tregs and rethinking cancer immunotherapy.Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.Immunosuppressive tumor microenvironment in cervical cancer patientsThe tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.Tecemotide: an antigen-specific cancer immunotherapy.Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.Immunotherapy in ovarian cancer.Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model.Treatment of lymphoma with adoptively transferred T cells.Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.Immunotherapy for Lung Cancer: Has it Finally Arrived?Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing miceDevelopment of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation.miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.The role of chemotherapy in the modern management of melanoma
P2860
Q28481351-D15B6A80-572C-421C-BCEA-AB0A335CEEDDQ34480557-BDC57360-1108-4AF0-B5E2-E2FDC0049E1FQ34625147-6704AF6F-8B5B-47F0-B878-4CB660A76C6FQ35238258-6770E049-173A-4F7A-A574-E6502E421079Q35603131-CC003232-06B0-4280-B7C6-8F9F4B0B6B79Q35871559-546A2BCB-1948-401F-B26D-48CD090EB503Q35886761-D0F1AB0E-DA1D-4548-A598-BA780E86F9BBQ35901282-91BD6369-E462-4A95-ADD3-551C24F09971Q36631249-96561EFF-2F59-402C-9469-2D222AA7C36CQ36707865-6048BE64-6A6A-4956-BFF5-18005ECD6EAEQ37419728-1D80B1AD-2770-41AE-BD5E-DEDB21694869Q37728232-78067F1D-7BB6-4ED2-9915-E884C9F20C78Q38265555-B38CC284-DB9E-490B-8284-3CB2037B9BEAQ38374526-CCA25704-0884-4856-8920-95EEBB21F1C7Q41979125-9F5AFC82-A683-4C30-A6BA-182B5C493933Q42563520-C3A68601-CE96-40B2-8FA8-67CBC79976DDQ57569574-FED9B18E-DAD2-4A69-8D16-9DC3928B4D84
P2860
Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Effect of low dose cyclophosph ...... depletion of the CD8+ subset.
@en
type
label
Effect of low dose cyclophosph ...... depletion of the CD8+ subset.
@en
prefLabel
Effect of low dose cyclophosph ...... depletion of the CD8+ subset.
@en
P1433
P1476
Effect of low dose cyclophosph ...... depletion of the CD8+ subset.
@en
P2093
Mastrangelo MJ
P304
P407
P577
1987-06-01T00:00:00Z